In the current market session, Thermo Fisher Scientific Inc. TMO price is at $401.51, after a 1.27% spike. However, over the past month, the stock fell by 1.35%, and in the past year, by 30.21%.

Tapestry's TPR short percent of float has fallen 17.98% since its last report. The company recently reported that it has 12.55 million shares sold short, which is 6.25% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.38 days to cover ...

Financial giants have made a conspicuous bullish move on Costco Wholesale. Our analysis of options history for Costco Wholesale COST revealed 50 unusual trades. Delving into the details, we found 42% of traders were bullish, while 32% showed bearish tendencies.

Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna MRNA revealed 20 unusual trades. Delving into the details, we found 40% of traders were bullish, while 45% showed bearish tendencies.

Investors with a lot of money to spend have taken a bearish stance on Cameco CCJ. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

MARA shares rise over 6% after the company reports a 35% month-over-month increase in Bitcoin production, reaching 950 BTC in May. The company hits a record 282 blocks earned and grows total Bitcoin holdings to 49,179, benefiting from its self-operated mining pool.

BofA survey shows 2025 software spending growth outlook trimmed to 9.9%, with firms cautious amid macro uncertainty. Data analytics tops spending priorities again; Microsoft, Snowflake, and Datadog seen as key AI and cloud beneficiaries. Rebound or breakdown?

Another Nasdaq-listed company is adopting a crypto-buying strategy-but not with Bitcoin.

In prostate cancer patients with BRCA mutations, niraparib plus AAP reduced progression risk by 48% and showed early survival benefits. CARVYKTI led to five-year remission in 33% of multiple myeloma patients, with a median overall survival of 60.7 months. Rebound or breakdown?

Micron shares rise nearly 4% after the company begins shipping samples of its new 1-gamma LPDDR5X memory, built for AI use in smartphones. The product targets faster, more efficient memory for mobile AI tasks. Rebound or breakdown?